JPRN-UMIN000039247已完成未知
A study of reducing discomfort in the eyes and nose after consuming herb powder when pollen from Cryptomeria japonica (known as sugi in Japanese) is dispersed. A double-blind, parallel group comparison study - A study of reducing discomfort in the eyes and nose after consuming herb powder when pollen from Cryptomeria japonica (known as sugi in Japanese) is dispersed. A double-blind, parallel group comparison study
imeQ RD inc.0 个研究点目标入组 28 人开始时间: 2020年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Those who are currently receiving some types of drug and Chinese medical treatments. 2. Those with acute rhinitis, sinusitis, nasal polyp, hypertrophic rhinitis, and deviated septum. 3. Those who had undergone intranasal surgery. 4. Those with coexisting bronchial asthma. 5. Those who have or had a severe disease of the liver, heart, kidneys, gastrointestinal tract, respiratory system, endocrine, and metabolism. 6. Those who are receiving specific hyposensitization therapy. 7. Those who take oral medication or nasal spray for antihistamines or anti-allergic drugs on a daily basis. 8. Those who take Lactobacillus preparation, supplements containing Lactobacillus, or yogurt on a daily basis. 9. Those who take food products with anti-allergic effects, such as "Tian Cha" derived from Chinese Blackberry leaves and "Memehana-cha" derived from 'Benifuki' cultivar, on a daily basis. 10. Those who may have allergic reactions to test food. 11. Those who are currently taking health food (such as supplements or food products to maintain or restore health), except for those who can temporarily stop taking the above health food at the time of submission of an informed consent document and remain the same until the end of this study. 12. Those who have a past and current medical history of drug or food allergy. 13. Those who are currently participating in another clinical trial or who had participated in another clinical trial conducted within a month prior to the submission of an informed consent document. 14. Those who are currently pregnant or breastfeeding and who want to become pregnant. 15. Heavy drinkers. 16. Smokers. 17. Those who experienced a feeling of being unwell or deterioration of health condition when they had blood drawn. 18. Those who may undergo lifestyle changes (such as a long trip) during the study period. 19. Those who were determined by the principal investigator to be unsuitable for participation in this clinical trial.
研究者
相似试验
已完成
Unknown
A study to evaluate eye and nose discomfort: a randomized, placebo-controlled, double-blind, parallel-group comparison studyHealthy Japanese subjectsJPRN-UMIN000049884KSO Corporation180
已完成
不适用
The test of the improvement effect for eyestrain of the Bilberry extractsEyestrainJPRN-UMIN000015861niversal Clinical Systems Co., Ltd.20
已完成
不适用
A study of the intraocular pressure lowering effect of topical application of ripasudil in clinical practiceGlaucomaJPRN-UMIN000025466Kobe University Graduate School of Medicine130
已完成
不适用
Verification of eye fatigue suppression effect by ingesting test foods. A placebo-controlled, Simple Randomization, double blind, cross over trial.healthy adultJPRN-UMIN000037406School of Allied Health Sciences, Kitasato University50
尚未招募
1 期
sing exosome to treat severe dry eyesSevere dry eye.Dry eye syndrome of unspecified lacrimal glandH04.129IRCT20170211032503N2Vision health research center30